Integral Health Asset Management’s Sana Biotechnology SANA Stock Holding History

Integral Health Asset Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.22M	Buy	3,200,000 +200,000	+7%	+$788K	0.44%	62
2025 Q4	$12.2M	Buy	3,000,000 +1,000,000	+50%	+$4.48M	0.61%	53
2025 Q3	$7.1M	Buy	2,000,000 +500,000	+33%	+$1.81M	0.48%	63
2025 Q2	$4.09M	Sell	1,500,000 -500,000	-25%	-$1.03M	0.37%	61
2025 Q1	$3.36M	Hold	2,000,000	–	–	0.36%	65
2024 Q4	$3.26M	Buy	2,000,000 +200,000	+11%	+$596K	0.28%	71
2024 Q3	$7.49M	Buy	1,800,000 +600,000	+50%	+$3.15M	0.84%	32
2024 Q2	$6.55M	Buy	1,200,000 +220,000	+22%	+$1.75M	0.62%	47
2024 Q1	$9.8M	Buy	+980,000	New	+$7.34M	0.91%	43

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Integral Health Asset Management's SANA Position: Q1 2026 in Review

Integral Health Asset Management increased its Sana Biotechnology (SANA) stake by 6.7% in Q1 2026, buying an estimated $788K and bringing the position to 3,200,000 shares worth $9.22M. The position accounts for 0.44% of the portfolio, ranked #62.

Integral Health Asset Management first reported a position in SANA in Q1 2024 and has held it in 9 quarters since. The position peaked at $12.2M in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

Integral Health Asset Management held 3,200,000 shares of Sana Biotechnology worth $9.22M as of Q1 2026.
Integral Health Asset Management bought 200,000 Sana Biotechnology shares in Q1 2026, an estimated $788K.
Sana Biotechnology made up 0.44% of Integral Health Asset Management's portfolio in Q1 2026, its #62 holding.
Integral Health Asset Management first reported a position in Sana Biotechnology in Q1 2024 and has held it in 9 quarters since.
Integral Health Asset Management's Sana Biotechnology position peaked at $12.2M in Q4 2025.
202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.